Overview of Dr. Yu
Dr. Anthony Yu is a cardiologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Harvard Medical School and has been in practice 10 years. He is one of 40 doctors at Memorial Sloan Kettering Cancer Center who specialize in Cardiology. He has more than 50 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2010 - 2013
University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
Harvard Medical SchoolClass of 2007
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2025
NY State Medical License 2010 - 2025
CT State Medical License 2023 - 2024
PA State Medical License 2007 - 2010- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification Start of enrollment: 2014 Jun 24
- A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients Start of enrollment: 2019 Mar 22
Publications & Presentations
PubMed
- 31 citationsCardiotoxicity of HER2-targeted therapies.Robert S Copeland-Halperin, Jennifer E. Liu, Anthony F. Yu
Current Opinion in Cardiology. 2019-07-01 - 129 citationsObesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-AnalysisCharles Guenancia, Annick Lefebvre, Daniela Cardinale, Anthony F. Yu, Sylvain Ladoire
Journal of Clinical Oncology. 2016-09-27 - 30 citationsOptimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin LymphomasBruce D. Cheson, Susan O'Brien, Michael S. Ewer, Marcus D. Goncalves, Azeez Farooki
Clinical Lymphoma, Myeloma & Leukemia. 2019-03-01
Press Mentions
Breast Cancer Linked to Higher Odds for Dangerous a-fibNovember 16th, 2021
Bad News on Anti-HER2 Heart EffectsJanuary 15th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
